Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,218 public trials 94 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

NCT00002816

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 33 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

NCT00005977

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
View all 119 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00967057

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Women's and Children's Hospital North Adelaide, South Australia, Australia
  • Birmingham Children's Hospital Birmingham, England, United Kingdom
  • Bristol Royal Hospital for Children Bristol, England, United Kingdom
  • Great Ormond Street Hospital for Children London, England, United Kingdom
View Trial Details
Completed

Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia

NCT00086775

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Jackson Oncology Associates, PLLC Jackson, Mississippi, United States
  • Cancer Institute of New Jersey at Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States
  • Western Pennsylvania Cancer Institute Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia

NCT00337246

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Birmingham Heartlands Hospital Birmingham, England, United Kingdom
  • Blackpool Victoria Hospital Blackpool, England, United Kingdom
  • Kent and Canterbury Hospital Canterbury, England, United Kingdom
  • St Helier Hospital Carshalton, England, United Kingdom
View all 16 locations
View Trial Details

Related conditions